Saturday, July 11, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “anti-”

1,068 pharma patents match "anti-" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 1,068
Index total 30,257
Page 37 / 45

Quick answer

This filtered view shows 1,068 pharmaceutical patents matching "anti-" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

1,068 results for “anti-” · 30,257 patents in full index Clear search

  1. US 8496938

    Anti-CD100 neutralizing neutralizing antibodies and methods of using the same

    VACCINEX, INC. · Granted Jul 30, 2013 · Expires Jul 25, 2033

    granted

  2. US 8481095

    Method for anti-oxidation, inhibiting activity and/or expression of matrix metalloproteinase, and/or inhibiting phosporylation of mitogen-activated protein kinase using flemingia macrophylla extract

    China Medical University · Granted Jul 9, 2013 · Expires Jul 4, 2033

    granted

  3. US 8465743

    Anti-vascular endothelial growth factor receptor-2 chimeric antigen receptors and use of same for the treatment of cancer

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jun 18, 2013 · Expires Jun 13, 2033

    granted

  4. US 8460660

    Anti-mesothelin antibodies

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Jun 11, 2013 · Expires Jun 6, 2033

    granted

  5. US 8455454

    miR 204, miR 211, their anti-miRs, and therapeutic uses of same

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jun 4, 2013 · Expires May 30, 2033

    granted

  6. US 8420665

    Anti-cancer compounds

    Northwestern University · Granted Apr 16, 2013 · Expires Apr 11, 2033

    granted

  7. US 8404817

    Humanized anti-prostate stem cell antigen monoclonal antibody

    The Regents of the University of California · Granted Mar 26, 2013 · Expires Mar 21, 2033

    granted

  8. US 8383785

    Anti-bacterial activity of 9-hydroxy derivatives of 6,11-bicyclolides

    Enanta Pharmaceuticals, Inc. · Granted Feb 26, 2013 · Expires Feb 21, 2033

    granted

  9. US 8383113

    Anti-ADDL antibodies and uses thereof

    Northwestern University · Granted Feb 26, 2013 · Expires Feb 21, 2033

    granted

  10. US 8367052

    Methods for promoting protection and regeneration of bone marrow using CXCL9 and anti-CXCL9 antibodies

    GENERAL REGENERATIVES, LTD. · Granted Feb 5, 2013 · Expires Jan 31, 2033

    granted

  11. US 8361471

    Immunostimulatory regimen comprising administering type 1 interferon and agonistic anti-CD40 antibody

    The Regents of the University of Colorado · Granted Jan 29, 2013 · Expires Jan 24, 2033

    granted

  12. US 8362211

    Anti-CD38 antibodies

    Takeda Pharmaceutical Company Limited · Granted Jan 29, 2013 · Expires Jan 24, 2033

    granted

  13. US 8357783

    Human anti-mesothelin monoclonal antibodies

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Jan 22, 2013 · Expires Jan 17, 2033

    granted

  14. US 8349371

    Method for anti-oxidation, inhibiting activity and/or expression of matrix metalloproteinase, and/or inhibiting phosphorylation of mitogen-activated protein kinase using neonauclea reticulata leaf extracts

    China Medical University · Granted Jan 8, 2013 · Expires Jan 3, 2033

    granted

  15. US 8343499

    Anti-arthropod vector vaccines, methods of selecting and uses thereof

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Jan 1, 2013 · Expires Dec 27, 2032

    granted

  16. US 8329664

    Anti-viral pyrimidine nucleoside derivatives

    University College Cardiff Consultants Limited · Granted Dec 11, 2012 · Expires Dec 6, 2032

    granted

  17. US 8329181

    Methods for treating B-cell lymphoma by administering an anti-CD20 antibody

    REGENERON PHARMACEUTICALS, INC. · Granted Dec 11, 2012 · Expires Dec 6, 2032

    granted

  18. US 8318156

    Anti-cocaine compositions and treatment

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Nov 27, 2012 · Expires Nov 22, 2032

    granted

  19. US 8298555

    Color cosmetic compositions for topical anti-aging skin treatment

    Discovery Limited · Granted Oct 30, 2012 · Expires Oct 25, 2032

    granted

  20. US 2012263625

    GLYCO-SUBSTITUTED DIHYDROXY-CHLORINS AND ß-FUNCTIONALIZED CHLORINS FOR ANTI-MICROBIAL PHOTODYNAMIC THERAPY

    AICHER DANIEL [DE] · Granted Oct 18, 2012 · Expires Oct 13, 2032

    granted

  21. US 8268786

    Anti-cancer tocotrienol analogues and associated methods

    First Tech International Limited · Granted Sep 18, 2012 · Expires Sep 13, 2032

    granted

  22. US 8258263

    Interferon-antibody fusion proteins demonstrating potent apoptotic and anti-tumor activities

    The Regents of the University of California · Granted Sep 4, 2012 · Expires Aug 30, 2032

    granted

  23. US 8198322

    Apoptotic and anti-tumor activities of metallo-salens

    The Board of Regents of the University of Texas System · Granted Jun 12, 2012 · Expires Jun 7, 2032

    granted

  24. US 8192741

    Method of treating rheumatoid arthritis with an anti-IL-6R antibody

    REGENERON PHARMACEUTICALS, INC. · Granted Jun 5, 2012 · Expires May 31, 2032

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.